Literature DB >> 6162695

Microvascular alterations develop in Syrian hamsters after the induction of diabetes mellitus by streptozotocin.

W L Joyner, W G Mayhan, R L Johnson, C K Phares.   

Abstract

Microvessels in the cheek pouch of the hamster were investigated to determine their structural, reactivity, and permeability characteristics after the induction of diabetes. To induce diabetes, hamsters were injected with streptozotocin (50 mg/kg body wt./day, i.p., for 3 days). Vehicle-injected, age-matched hamsters were the controls. Diabetic hamsters were characterized by elevated serum glucose (greater than 300 mg/dl) and triglycerides and decreased serum insulin (50%). Microvascular studies were completed on cheek pouch microvessels suffused with Ringer's solution (37 degrees C, pH 7.4) bubbled with 95% N2-5% CO2. Vascular dimensions and reactivity of selected arterioles and venules to microapplications of norepinephrine were determined with a video micrometer using intravital microscopy. Restrictiveness of the microvascular membranes to fluorescein-labeled dextran fractions (mol wt: 150,000; 40,000; 20,000 daltons) was measured by determining the number of leaky sites. Stimulation of membrane permeability by histamine was investigated. There were no major alterations in arteriolar lumen and wall diameters, whereas venular lumen diameters were increased in hamsters diabetic for two months. Likewise, arteriolar responses to norepinephrine were not altered by diabetes; however, venular responses were decreased at two months. The restrictiveness of the vascular membrane to various dextran fractions was dramatically decreased in the diabetic animals at two months. Histamine did not alter microvascular leakage in the diabetic as it did in the normal hamsters. These studies indicate that microvascular alterations, venular dilation, and increased permeability to large molecules occur in the diabetic hamster within two months after the induction of diabetes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6162695     DOI: 10.2337/diab.30.2.93

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  Early arteriolar and capillary changes in streptozotocin-induced diabetic rats and intraperitoneal hyperglycaemic rats.

Authors:  H G Bohlen; K D Hankins
Journal:  Diabetologia       Date:  1982-05       Impact factor: 10.122

2.  Impaired dynamic cerebral autoregulation at rest and during isometric exercise in type 2 diabetes patients.

Authors:  Lauro C Vianna; Shekhar H Deo; Areum K Jensen; Seth W Holwerda; Matthew C Zimmerman; Paul J Fadel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-01-16       Impact factor: 4.733

3.  Alterations in Ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes.

Authors:  G N Pierce; M J Kutryk; N S Dhalla
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

4.  Coronary microvascular abnormalities in the hypertensive-diabetic rat. A primary cause of cardiomyopathy?

Authors:  S M Factor; T Minase; S Cho; F Fein; J M Capasso; E H Sonnenblick
Journal:  Am J Pathol       Date:  1984-07       Impact factor: 4.307

5.  A simple deep breathing test reveals altered cerebral autoregulation in type 2 diabetic patients.

Authors:  C M Brown; H Marthol; U Zikeli; D Ziegler; M J Hilz
Journal:  Diabetologia       Date:  2008-02-29       Impact factor: 10.122

6.  Functional and morphologic changes associated with insulinoma transplantation into diabetic rats.

Authors:  D S Reintgen; B Croker; C Verveart; H F Seigler
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

7.  Correlation between retinal vascular parameters and cystatin C in patients with type 2 diabetes.

Authors:  Qiong Wang; Aili Yang; Fei Sun; Maiye Zhang; Xiayu Xu; Bin Gao
Journal:  Acta Diabetol       Date:  2021-05-21       Impact factor: 4.280

8.  Vimentin and laminin are altered on cheek pouch microvessels of streptozotocin-induced diabetic hamsters.

Authors:  Jemima Fuentes R Silva; Fatima Z G A Cyrino; Marisa M D Breitenbach; Eliete Bouskela; Jorge José Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.